Edition:
United Kingdom

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

11.13USD
25 Sep 2018
Change (% chg)

$-0.48 (-4.13%)
Prev Close
$11.61
Open
$11.53
Day's High
$11.56
Day's Low
$10.69
Volume
114,628
Avg. Vol
40,493
52-wk High
$38.68
52-wk Low
$6.99

Latest Key Developments (Source: Significant Developments)

Menlo Therapeutics Q2 Loss Per Share $0.36
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Menlo Therapeutics Inc ::MENLO THERAPEUTICS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q2 LOSS PER SHARE $0.36.Q2 EARNINGS PER SHARE VIEW $-0.79 -- THOMSON REUTERS I/B/E/S.  Full Article

Menlo Therapeutics Reports Qtrly Loss Per Share $0.72
Wednesday, 9 May 2018 

May 9 (Reuters) - Menlo Therapeutics Inc ::MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.QTRLY LOSS PER SHARE $0.72.LOWERING ITS OPERATING EXPENSE GUIDANCE FOR FULL YEAR 2018 TO A RANGE OF APPROXIMATELY $68.0 MILLION TO $78.0 MILLION.  Full Article

Menlo Therapeutics Says Japanese Phase 2 Trial Of Serlopitant Halted
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Menlo Therapeutics Inc ::MENLO THERAPEUTICS - CO'S PARTNERS FOR COMMERCIALIZATION OF SERLOPITANT IN JAPAN, INFORMED DECISION TO HALT JAPANESE PHASE 2 CLINICAL TRIAL OF SERLOPITANT.MENLO SAYS JT TORII HAS INDICATED THEY ARE REEVALUATING THEIR SERLOPITANT DEVELOPMENT PROGRAM BASED UPON EVOLVING COMMERCIAL CONSIDERATIONS IN JAPAN.MENLO THERAPEUTICS INC - BASED UPON COMMUNICATION WITH JT TORII, CO EXPECTS JT TORII LICENSE AGREEMENT FOR SERLOPITANT WILL ULTIMATELY BE TERMINATED.  Full Article

Menlo Therapeutics Prices IPO Of 7 Mln Shares At $17/Share
Thursday, 25 Jan 2018 

Jan 24 (Reuters) - Menlo Therapeutics Inc ::ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING OF COMMON STOCK.SAYS INITIAL PUBLIC OFFERING OF 7.00 MILLION COMMON SHARES PRICED AT $17.00PER SHARE.  Full Article

Menlo Therapeutics Now Sees IPO Of 6.5 Mln Shares Of Common Stock Priced Between $16 And $17 Per Share
Tuesday, 23 Jan 2018 

Jan 23 (Reuters) - Menlo Therapeutics Inc ::MENLO THERAPEUTICS INC NOW SEES IPO OF 6.5 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $16.00 AND $17.00 PER SHARE - SEC FILING.MENLO THERAPEUTICS INC SAYS IT HAD PREVIOUSLY EXPECTED IPO OF 5.67 MILLION SHARES OF COMMON STOCK PRICED BETWEE $14.00 AND $16.00 PER SHARE.  Full Article